4th Quarter - Report

PURDUE PHARMA, LP for PURDUE PHARMA LP

Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR 3200America's Affordable Health Choices Act of 2009 S 1796America's Healthy Future Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660 National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515 Patent Reform Act of 2009 S 610 Patent Reform Act of 2009 HR 3590Patient Protection and Affordable Care Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S 301 Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369 Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1359 (111th), H.R. 1706 (111th), H.R. 1260 (111th), H.R. 1191 (111th), H.R. 1427 (111th), H.R. 756 (111th), H.R. 3590 (111th), H.R. 3200 (111th), H.R. 1298 (111th)

Alcohol and Drug Abuse ALC

HR 3200America's Affordable Health Choices Act of 2009 S 1796America's Healthy Future Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660 National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515 Patent Reform Act of 2009 S 610 Patent Reform Act of 2009 HR 3590Patient Protection and Affordable Care Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S 301 Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369 Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1298 (111th), H.R. 1260 (111th), H.R. 3200 (111th), H.R. 756 (111th), H.R. 1706 (111th), H.R. 1427 (111th), H.R. 3590 (111th), H.R. 1191 (111th), H.R. 1359 (111th)

Health Issues HCR

HR 3200America's Affordable Health Choices Act of 2009 S 1796America's Healthy Future Act of 2009 HR 756National Pain Care Policy Act of 2009 S 660 National Pain Care Policy Act of 2009 HR 1260Patent Reform Act of 2009 S 515 Patent Reform Act of 2009 S 610 Patent Reform Act of 2009 HR 3590Patient Protection and Affordable Care Act HR 1298Pharmaceutical Market Access and Drug Safety Act of 2009 S 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S 301 Physician Payments Sunshine Act of 2009 HR 1427Promoting Innovation and Access to Life-Saving Medicine Act S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 1706Protecting Consumer Access to Generic Drugs Act of 2009 S 369 Preserve Access to Affordable Generics Act of 2009 HR 1191Safe Drug Disposal Act of 2009 S 1336Safe Drug Disposal Act of 2009 HR 1359Secure and Responsible Drug Disposal Act of 2009 S 1292Secure and Responsible Drug Disposal Act of 2009 Anti- counterfeiting legislation concerning drugs Healthcare Reform Hearings related to prescription drug abuse and prevention Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1359 (111th), H.R. 1427 (111th), H.R. 3590 (111th), H.R. 1191 (111th), H.R. 1298 (111th), H.R. 1706 (111th), H.R. 756 (111th), H.R. 3200 (111th), H.R. 1260 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.